{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:41:26Z","timestamp":1761198086594,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s40268-022-00397-0","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T10:04:27Z","timestamp":1661421867000},"page":"183-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Roxadustat for SARS-CoV-2 Infection: Old Signaling Raised New Hopes"],"prefix":"10.1007","volume":"22","author":[{"given":"Luay","family":"Alkazmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gomaa","family":"Mostafa-Hedeab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"De Waard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed M.","family":"Kabrah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9555-7300","authenticated-orcid":false,"given":"Hebatallah M.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus","family":"Simal-Gandara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"issue":"25","key":"397_CR1","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1056\/NEJMe2117100","volume":"385","author":"P Parfrey","year":"2021","unstructured":"Parfrey P. Hypoxia-inducible factor prolyl hydroxylase inhibitors for anemia in CKD. N Engl J Med. 2021;385(25):2390\u20131.","journal-title":"N Engl J Med"},{"issue":"9","key":"397_CR2","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1093\/ndt\/gfab057","volume":"36","author":"E Shutov","year":"2021","unstructured":"Shutov E, Su\u0142owicz W, Esposito C, et al. Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a phase 3, randomized, double-blind, placebo-controlled study (ALPS). Nephrol Dial Transplant. 2021;36(9):1629\u201339.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"397_CR3","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1074\/jbc.RA118.004902","volume":"294","author":"P Miikkulainen","year":"2019","unstructured":"Miikkulainen P, H\u00f6gel H, Seyednasrollah F, et al. Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma. J Biol Chem. 2019;294(10):3760\u201371.","journal-title":"J Biol Chem"},{"issue":"12","key":"397_CR4","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/s41401-020-00554-8","volume":"41","author":"ZO Serebrovska","year":"2020","unstructured":"Serebrovska ZO, Chong EY, Serebrovska TV. Hypoxia, HIF-1\u03b1, and COVID-19: from pathogenic factors to potential therapeutic targets. Acta Pharmacol Sin. 2020;41(12):1539\u201346.","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"397_CR5","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1007\/s11010-021-04232-z","volume":"476","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, et al. The potential role of neopterin in Covid-19: a new perspective. Mol Cell Biochem. 2021;476(11):4161\u20136.","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"397_CR6","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.ajpath.2017.04.012","volume":"187","author":"J McClendon","year":"2017","unstructured":"McClendon J, Jansing NL, Redente EF, et al. Hypoxia-inducible factor 1\u03b1 signaling promotes repair of the alveolar epithelium after acute lung injury. Am J Pathol. 2017;187(8):1772\u201386.","journal-title":"Am J Pathol"},{"issue":"10","key":"397_CR7","first-page":"3301","volume":"118","author":"T Eckle","year":"2008","unstructured":"Eckle T, Grenz A, Laucher S, et al. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Investig. 2008;118(10):3301\u201315.","journal-title":"J Clin Investig"},{"issue":"6","key":"397_CR8","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1053\/j.ajkd.2016.12.011","volume":"69","author":"N Gupta","year":"2017","unstructured":"Gupta N, Wish JB. Hypoxia-inducible factor prolyl hydroxylase inhibitors: a potential new treatment for anemia in patients with CKD. Am J Kidney Dis. 2017;69(6):815\u201326.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"397_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109020","volume":"35","author":"PA Wing","year":"2021","unstructured":"Wing PA, Keeley TP, Zhuang X, et al. Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells. Cell Rep. 2021;35(3):109020.","journal-title":"Cell Rep"},{"issue":"11","key":"397_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.621054","volume":"29","author":"AA Poloznikov","year":"2021","unstructured":"Poloznikov AA, Nersisyan SA, Hushpulian DM, et al. HIF prolyl hydroxylase inhibitors for COVID-19 treatment: pros and cons. Front Pharmacol. 2021;29(11):621054.","journal-title":"Front Pharmacol."},{"issue":"4","key":"397_CR11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/ckj\/sfaa149","volume":"13","author":"L Del Vecchio","year":"2020","unstructured":"Del Vecchio L, Locatelli F. Hypoxia response and acute lung and kidney injury: possible implications for therapy of COVID-19. Clin Kidney J. 2020;13(4):494\u20139.","journal-title":"Clin Kidney J"},{"issue":"10","key":"397_CR12","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1161\/ATVBAHA.121.316495","volume":"41","author":"J Zhao","year":"2021","unstructured":"Zhao J, Xu Y, Xie J, et al. Roxadustat does not affect platelet production, activation, and thrombosis formation. Arterioscler Thromb Vasc Biol. 2021;41(10):2523\u201337.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"397_CR13","doi-asserted-by":"publisher","unstructured":"Hosseinzadeh MH, Goodarzi A, Malekan M, et al. Melatonin increased hypoxia\u2010inducible factor (HIF) by inhibiting prolyl hydroxylase: a hypothesis for treating anemia, ischemia, and covid\u201019. Clin Exp Pharmacol Physiol. 2022. https:\/\/doi.org\/10.1111\/1440-1681.13639.","DOI":"10.1111\/1440-1681.13639"},{"issue":"7","key":"397_CR14","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1021\/acscentsci.0c01537","volume":"7","author":"R Amraei","year":"2021","unstructured":"Amraei R, Yin W, Napoleon MA, et al. CD209L\/L-SIGN and CD209\/DC-SIGN act as receptors for SARS-CoV-2. ACS Cent Sci. 2021;7(7):1156\u201365.","journal-title":"ACS Cent Sci"},{"issue":"67","key":"397_CR15","doi-asserted-by":"publisher","first-page":"eabm5505","DOI":"10.1126\/sciimmunol.abm5505","volume":"7","author":"SR Paludan","year":"2022","unstructured":"Paludan SR, Mogensen TH. Innate immunological pathways in COVID-19 pathogenesis. Sci Immunol. 2022;7(67):eabm5505.","journal-title":"Sci Immunol."},{"issue":"2","key":"397_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/bcp.15023","volume":"88","author":"A Takada","year":"2022","unstructured":"Takada A, Shibata T, Shiga T, Groenendaal-van de Meent D, Komatsu K. Population pharmacokinetics of roxadustat in Japanese dialysis-dependent chronic kidney disease patients with anaemia. Br J Clin Pharmacol. 2022;88(2):787\u201397.","journal-title":"Br J Clin Pharmacol."},{"key":"397_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.644095","volume":"8","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Guerreiro SG, Cruz-Martins N, Batiha GE. COVID-19 in relation to hyperglycemia and diabetes mellitus. Front Cardiovasc Med. 2021;8: 644095.","journal-title":"Front Cardiovasc Med."},{"key":"397_CR18","first-page":"1","volume":"24","author":"T Akizawa","year":"2022","unstructured":"Akizawa T, Tanaka-Amino K, Otsuka T, Yamaguchi Y. Clinical parameters among patients in Japan with anemia and non-dialysis-dependent chronic kidney disease with and without diabetes mellitus who received roxadustat. Clin Exp Nephrol. 2022;24:1\u20138.","journal-title":"Clin Exp Nephrol."},{"issue":"1","key":"397_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/13543784.2018.1417386","volume":"27","author":"L Del Vecchio","year":"2018","unstructured":"Del Vecchio L, Locatelli F. Roxadustat in the treatment of anaemia in chronic kidney disease. Expert Opin Investig Drugs. 2018;27(1):125\u201333.","journal-title":"Expert Opin Investig Drugs"},{"key":"397_CR20","first-page":"1","volume":"13","author":"G El-Saber Batiha","year":"2022","unstructured":"El-Saber Batiha G, Al-Gareeb AI, Saad HM, Al-Kuraishy HM. COVID-19 and corticosteroids: a narrative review. Inflammopharmacology. 2022;13:1\u20137.","journal-title":"Inflammopharmacology"},{"key":"397_CR21","first-page":"1","volume":"29","author":"G Mostafa-Hedeab","year":"2022","unstructured":"Mostafa-Hedeab G, Al-Kuraishy HM, Al-Gareeb AI, Jeandet P, Saad HM, Batiha GE-S. A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19. Inflammopharmacology. 2022;29:1\u201311.","journal-title":"Inflammopharmacology"}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-022-00397-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40268-022-00397-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-022-00397-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T13:27:21Z","timestamp":1661952441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40268-022-00397-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1007\/s40268-022-00397-0","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"type":"print","value":"1174-5886"},{"type":"electronic","value":"1179-6901"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"assertion":[{"value":"15 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.D.W. thanks the French Agence Nationale de la Recherche and the R\u00e9gion Pays de la Loire for financial support on Covid-19 research (ANR Flash COVID 19 call - name: CoV2-E-TARGET - grant number: 2020 07132)..","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Nil.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"The authors equally participated in the development of the manuscript and provided their final approval of all content and submission for publication.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}